AbstractThe Veterans Health Administration is implementing a pragmatic trial research program, called Point of Care Research (POC-R). The purpose of this telephone survey in which respondents were randomized to different framing conditions of the purpose of POC-R was to determine the impact of differing frames of the purpose of POC-R on attitudes towards the program and intentions to participate; and the relative importance of different beliefs and attitudes in discriminating low vs. high intenders to participate in POC-R. The survey addressed veterans’ perceptions and attitudes towards POC-R, and their willingness to participate in a pragmatic trial. Overall, respondents felt positively towards POC-R and intended to participate. Differing ...
Pragmatic clinical trials (PCTs) are considered a valuable means to directly improve day-to-day pati...
BACKGROUND: We recently published a systematic review of different healthcare settings (such as outp...
Abstract Background: Communication with patients contemplating Phase 1 cancer trial participation ...
AbstractThe Veterans Health Administration is implementing a pragmatic trial research program, calle...
Point-of-care research (POCr) is part of a larger effort to advance the Veterans Health Administrati...
AbstractBackground/AimsPragmatic clinical trials (PCTs) represent an increasingly used strategy for ...
The concomitant problems of underenrollment and selective enrollment limit the efficiency of many ra...
Background Use of patient-reported outcomes (PROs) and patient and public engagement are critical in...
Patients who agree and those who refuse clinical trial entry may differ in attitudes towards decisio...
Recruitment to trials is known to be difficult. Previous research suggests that a crucial factor may...
This work is supported by the Canadian Institutes of Health Research through the Project Grant compe...
AbstractRecruitment to clinical trials is essential. The aims of the study were to investigate assoc...
Previous studies have shown that a majority of patients cite altruistic motives, such as contributin...
There are few data on patient and public involvement (PPI) in pragmatic trials. We aimed to describe...
BACKGROUND AND OBJECTIVE: Feasibility studies are increasingly being used to support the development...
Pragmatic clinical trials (PCTs) are considered a valuable means to directly improve day-to-day pati...
BACKGROUND: We recently published a systematic review of different healthcare settings (such as outp...
Abstract Background: Communication with patients contemplating Phase 1 cancer trial participation ...
AbstractThe Veterans Health Administration is implementing a pragmatic trial research program, calle...
Point-of-care research (POCr) is part of a larger effort to advance the Veterans Health Administrati...
AbstractBackground/AimsPragmatic clinical trials (PCTs) represent an increasingly used strategy for ...
The concomitant problems of underenrollment and selective enrollment limit the efficiency of many ra...
Background Use of patient-reported outcomes (PROs) and patient and public engagement are critical in...
Patients who agree and those who refuse clinical trial entry may differ in attitudes towards decisio...
Recruitment to trials is known to be difficult. Previous research suggests that a crucial factor may...
This work is supported by the Canadian Institutes of Health Research through the Project Grant compe...
AbstractRecruitment to clinical trials is essential. The aims of the study were to investigate assoc...
Previous studies have shown that a majority of patients cite altruistic motives, such as contributin...
There are few data on patient and public involvement (PPI) in pragmatic trials. We aimed to describe...
BACKGROUND AND OBJECTIVE: Feasibility studies are increasingly being used to support the development...
Pragmatic clinical trials (PCTs) are considered a valuable means to directly improve day-to-day pati...
BACKGROUND: We recently published a systematic review of different healthcare settings (such as outp...
Abstract Background: Communication with patients contemplating Phase 1 cancer trial participation ...